Therapeutic Potential of the Novel Monoclonal Antibody 7-4G against HBsAg in a Mouse Model of Chronic Hepatitis B Virus Infection
Abuduwaili, M.; Makokha, G. N.; Naderi, M.; Sakai, H.; Yamamoto, A.; Sakaguchi, T.; Matsumoto, T.; Shirouzu, M.; Seishi, K.; Yamamoto, A.; Kubo, Y.; Matsushita, M.; Inoue, Y.; Shankhajit, D.; Hijikata, M.; Chayama, K.
Show abstract
Chronic hepatitis B virus (HBV) infection remains a major global health challenge because current antiviral therapies rarely achieve complete viral clearance. We evaluated the antiviral activity of a newly developed monoclonal antibody, 7-4G mAb, directed against the hepatitis B surface antigen (HBsAg). The antibody showed specific binding to the p27 component of HBsAg and efficiently removed HBV-related particles from patient serum in vitro. Significant HBV neutralizing activity of 7-4G mAb was observed in primary human hepatocytes and in humanized mouse models. In persistently HBV-infected PXB mice, a single administration of 7-4G mAb, either alone or in combination with another monoclonal antibody, reduced serum HBsAg levels and HBV DNA levels by two orders magnitude for two weeks after the treatment. In half of the treated mice, suppression of both viral markers was maintained through the study period, whereas rebound occurred within three to four weeks in the remaining animals. In addition, 7-4G mAb enhanced the HBV DNA-lowering effect of entecavir, a known anti-HBV drug. These findings support the further development of 7-4G mAb as part of an innovative HBV treatment strategy, addressing limitations of existing therapies and advancing toward a more effective HBV management solution.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Host poly(A) polymerases PAPD5 and PAPD7 provide two layers of protection that ensure the integrity and stability of hepatitis B virus RNA 95%
- Class A capsid assembly modulator apoptotic elimination of hepatocytes with high HBV core antigen level in vivo is dependent on de novo core protein translation 95%
- Understanding hepatitis B virus dynamics and the antiviral effect of interferon-alpha treatment in humanized chimeric mice 93%
Similar papers in this journal
- PD-L1 upregulation by IFN-α/γ-mediated Stat1 suppresses anti-HBV T cell response 96%
- Epidemiological survey of serum titers from adults against various Gram-negative bacterial V-antigens 93%
- The Dual-Specificity Kinase Dyrk1A Interacts With The Hepatitis B Virus Genome And Regulates The Production Of Viral RNA 93%
Similar papers in this journal
- Immunodominant and neutralizing linear B cell epitopes spanning the spike and membrane proteins of Porcine Epidemic Diarrhea Virus 94%
- RBM39 alters phosphorylation of c-Jun and binds to viral RNA to promote PRRSV proliferation 92%
- Virus-like particles (VLPs) are efficient tools for boosting mRNA-induced antibodies 92%
Similar papers in this journal
- Evaluation of the Safety and Efficacy of the Respiratory Syncytial Virus FG Chimeric Vaccine KD-409 in Rodent Models for Maternal and Pediatric Vaccination 93%
- Protective human anti-poxvirus monoclonal antibodies are generated from rare memory B cells isolated by multicolor antigen tetramers 92%
- Clinical advancement of patients infected with SARS-CoV-2 Omicron variant in Shanghai, China 92%
Similar papers in this journal
- The kinesin KIF4 mediates HBV/HDV entry through regulation of surface NTCP localization and can be targeted by RXR agonists in vitro. 95%
- Detection and characterization of Hepatitis B virus double-stranded linear DNA-derived covalently closed circular DNA in chronic hepatitis B patients 95%
- Various miRNAs are involved in efficient HCV replication 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.